BOUNDLESS BIO, INC. APIC, Share-based Payment Arrangement, Recognition and Exercise
BOUNDLESS BIO, INC. (BOLD) reported APIC, Share-based Payment Arrangement, Recognition and Exercise of $6.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions · last filed 2026-03-09
- BOUNDLESS BIO, INC. apic, share-based payment arrangement, recognition and exercise for the quarter ending 2024-09-30 was $1.00K, a 66.67% decline year-over-year.
- BOUNDLESS BIO, INC. apic, share-based payment arrangement, recognition and exercise for the quarter ending 2024-06-30 was $2.00K, a 94.44% decline year-over-year.
- BOUNDLESS BIO, INC. apic, share-based payment arrangement, recognition and exercise for the quarter ending 2024-03-31 was $2.00K, a 96.15% decline year-over-year.
- BOUNDLESS BIO, INC. apic, share-based payment arrangement, recognition and exercise for the quarter ending 2023-09-30 was $3.00K.
- BOUNDLESS BIO, INC. apic, share-based payment arrangement, recognition and exercise for fiscal 2024 was $6.00K, a 93.48% decline from fiscal 2023.
- BOUNDLESS BIO, INC. apic, share-based payment arrangement, recognition and exercise for fiscal 2023 was $92.00K.
| Period end | APIC, Share-based Payment Arrangement, Recognition and Exercise 3 month | APIC, Share-based Payment Arrangement, Recognition and Exercise 6 month | APIC, Share-based Payment Arrangement, Recognition and Exercise 9 month | APIC, Share-based Payment Arrangement, Recognition and Exercise 12 month |
|---|---|---|---|---|
| 2024-12-31 | $6.00K 10-K · filed 2026-03-09 | |||
| 2024-09-30 | $1.00K 10-Q · filed 2025-11-05 | $3.00K derived: sum of 2 quarters · filed 2025-11-05 | $5.00K derived: sum of 3 quarters · filed 2025-11-05 | |
| 2024-06-30 | $2.00K 10-Q · filed 2025-11-05 | $4.00K derived: sum of 2 quarters · filed 2025-11-05 | ||
| 2024-03-31 | $2.00K 10-Q · filed 2025-11-05 | |||
| 2023-12-31 | $92.00K 10-K · filed 2025-03-27 | |||
| 2023-09-30 | $3.00K 10-Q · filed 2024-11-07 | $39.00K derived: sum of 2 quarters · filed 2024-11-07 | $91.00K derived: sum of 3 quarters · filed 2024-11-07 | |
| 2023-06-30 | $36.00K 10-Q · filed 2024-11-07 | $88.00K derived: sum of 2 quarters · filed 2024-11-07 | ||
| 2023-03-31 | $52.00K 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |